To further investigate the molecular mechanisms of therapeutic efficacy of indirubin in vivo, we quantified the percentage of CD4+CD25+Foxp3+ Tregs from the spleen and thymus as well as the expression of PD1, PDL1 in the ITP mice. This evidence concerns the gene PDCD1 and autoimmune thrombocytopenic purpura.